Pneumonia Testing Market Size Is Estimated To Reach $3.0 Bil...| MENAFN.COM

Saturday, 01 October 2022 02:21 GMT

Pneumonia Testing Market Size Is Estimated To Reach $3.0 Billion By 2030, Registering A CAGR Of 6.5%

(MENAFN- EIN Presswire)

Pneumonia testing market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

PORTLAND, OREGON, UNITED STATES, September 21, 2022 / / -- Pneumonia Testing Market Size was valued at $1.6 billion in 2020, and is estimated to reach $3.0 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030. Pneumonia is a type of lung infection caused by bacteria, such as the Streptococcus pneumonia virus, fungi, and parasites. In pneumonia, the air sacs of the lungs called alveoli are filled with fluid or pus that causes inflammation. The symptoms of pneumonia include short breathing, fever, chest pain, nausea & vomiting. However, these clinical symptoms overlap with many other diseases, such as asthma, bronchitis, and the common cold, making it difficult to diagnose pneumonia. Physicians recommend tests such as blood tests, sputum tests, pleural fluid cultures, and pulse oximetry tests to confirm the onset of pneumonia.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

โ€ขAbbott Laboratories
โ€ขThermo Fisher Scientific Inc.
โ€ขF-Hoffmann la Roche Ltd.
โ€ขHologic Inc.
โ€ขDickenson and Company
โ€ขMeridian Biosciences
โ€ขQuest Diagnostics
โ€ขBio-Rad Laboratories Inc.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

This disease is most prevalent in South Asia and African countries. The key factors that drive Pneumonia Testing Market Growth include an increase in technological advancement in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in point of care (POC) tests.

Moreover, an increase in awareness toward early diagnosis and a rise in government expenditures on healthcare fuel the market growth. However, the limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, the surge in the adoption of molecular diagnostic testing and high untapped market potential in developing countries are anticipated to provide lucrative growth opportunities for the market.

The Pneumonia Testing Industry is segmented on the basis of method, technology, type & end-user region. In terms of method, it is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is classified into hospitals, diagnostic laboratories, home care, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The POC testing segment was the major contributor to the market in 2020, due to multiple benefits offered by this technique, such as technological advancements, ease of use, and rapid results. The analyzers segment is estimated to register the highest growth rate during the forecast period, owing to t their frequent usage for pneumonia tests from 2020โ€“to 2030.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ

๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

โ€ขBy the method, the point of care test was the highest contributor to the market in 2020.
โ€ขBy technology, the enzyme-linked immunosorbent assay (ELISA) was the highest contributor to the Pneumonia Testing Industry in 2020.
โ€ขBy type, the analyzers were the highest contributor to the market in 2020.
โ€ขBy end-user, the hospitals were the highest contributor to the market in 2020.
โ€ขRegion-wise, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Blood Market

Lateral Flow Assays Market

๐€๐ฅ๐ฌ๐จ ๐‘๐ž๐š๐ ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐๐ฅ๐จ๐ :

Singapore MRI Systems Market --

Singapore Pneumonia Testing Market --

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions.' AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Allied Market Research
Allied Market Research
+ +1-800-792-5285
email us here
Visit us on social media:


Legal Disclaimer:
MENAFN provides the information โ€œas isโ€ without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.